Understanding Chronic Inflammatory Response Syndrome (CIRS) from Mould

In the United Kingdom, where damp housing is an endemic issue affecting an estimated 3.8 million homes, the health implications of water-damaged buildings extend far beyond simple allergies. Chronic Inflammatory Response Syndrome, or CIRS, is a complex, progressive condition that occurs when the body's innate immune system becomes trapped in a state of permanent activation. Unlike a standard allergic reaction to mould spores, CIRS is a systemic inflammatory storm triggered by biotoxins—including mycotoxins, volatile organic compounds (VOCs), and cell wall fragments like beta-glucans—that the body cannot properly process or excrete. For approximately 25 percent of the population, a specific genetic predisposition involving the Human Leukocyte Antigen (HLA-DR) gene means their immune system fails to recognize these toxins as threats, allowing them to circulate indefinitely and wreak havoc on multiple organ systems. ## The Genetic Mechanism of Biotoxin Illness. The core of CIRS lies in the failure of the adaptive immune system.

In a healthy individual, when biotoxins enter the body, the immune system identifies them, creates antibodies, and clears them via the liver and bile. However, those with HLA-DR genetic variations lack the 'molecular mirrors' needed to identify these specific toxins. Consequently, the toxins remain in the body, continuously reabsorbed through the enterohepatic circulation. This leads to a state of chronic innate immune activation where the body produces a constant stream of inflammatory cytokines. This 'cytokine storm' leads to the various symptoms associated with mould illness, including debilitating fatigue, joint pain, and cognitive impairment.

In the UK, many patients are misdiagnosed with Fibromyalgia or Chronic Fatigue Syndrome (ME/CFS) because the underlying environmental trigger—the damp building—is never identified. ## The Hormonal and Neurological Impact. As CIRS progresses, it disrupts the hypothalamic-pituitary-adrenal (HPA) axis, leading to significant hormonal imbalances. One of the hallmark markers of CIRS is a deficiency in Melanocyte-Stimulating Hormone (MSH). MSH is a master regulator of many biological processes; when it is low, patients often experience chronic pain, increased gut permeability, and sleep disturbances. Furthermore, CIRS patients often show a deficiency in Antidiuretic Hormone (ADH), which explains why many mould-sensitive individuals experience frequent urination, excessive thirst, and an inability to maintain electrolyte balance.

Neurologically, the inflammation can cross the blood-brain barrier, leading to 'brain fog' and executive dysfunction, which are often the most distressing symptoms for those living in mouldy environments. ## Identifying the Multi-System Symptoms. Because CIRS affects the entire body, the symptom list is extensive and diverse. Patients often present with a cluster of symptoms across at least 8 to 13 different categories. These include respiratory issues like sinus congestion and shortness of breath, neurological issues like tremors and memory loss, and musculoskeletal issues like migrating joint pain. A key diagnostic tool in the UK is the Visual Contrast Sensitivity (VCS) test, which measures the neurological ability to detect gray-scale patterns.

Since mycotoxins affect the optic nerve and neurological processing, a fail on this test is a strong indicator of biotoxin illness. This, combined with blood markers like TGF-beta1 and C4a, provides a rigorous framework for diagnosis that goes beyond subjective reporting. ## Practical Steps for Recovery and Remediation. The first and most critical step in addressing CIRS is 'Removal from Exposure.' No amount of supplementation or detoxification can overcome a living environment that is actively poisoning the occupant. In the UK, this often means professional mould remediation or, in some cases, moving to a new property. Once the environment is safe, the recovery protocol typically involves using sequestering agents—binders—to catch the toxins in the digestive tract and prevent their reabsorption.

These can include prescription resins like cholestyramine or natural binders like activated charcoal and bentonite clay, though these must be used under clinical supervision to avoid side effects. Supporting the liver and ensuring the drainage pathways are open is equally essential to ensure the toxins actually leave the body. Key Takeaways: 1. CIRS is a genetic inability to clear biotoxins, affecting 25% of the UK population. 2. It is characterized by chronic inflammation rather than a simple allergy. 3.

Diagnosis requires looking at HLA-DR genetics and specific inflammatory markers. 4. Recovery is impossible without first removing oneself from the water-damaged environment.